Evolva Holding SA Stock price

Equities

EVE

CH1262055788

Biotechnology & Medical Research

Delayed Swiss Exchange 04:00:20 2024-03-28 am EDT 5-day change 1st Jan Change
1 CHF 0.00% Intraday chart for Evolva Holding SA +23.15% +38.89%
Sales 2021 9.88M 10.9M Sales 2022 15.54M 17.15M Capitalization 91.05M 100M
Net income 2021 -41M -45.25M Net income 2022 -43M -47.46M EV / Sales 2021 12.8 x
Net cash position 2021 161K 178K Net Debt 2022 9.91M 10.94M EV / Sales 2022 6.5 x
P/E ratio 2021
-2.86 x
P/E ratio 2022
-2.02 x
Employees 49
Yield 2021 *
-
Yield 2022
-
Free-Float 67.85%
More Fundamentals * Assessed data
Dynamic Chart
1 week+23.15%
Current month+58.73%
1 month+58.73%
3 months+40.06%
6 months-62.96%
Current year+38.89%
More quotes
1 week
0.86
Extreme 0.86
1.07
1 month
0.62
Extreme 0.624
1.09
Current year
0.62
Extreme 0.616
1.09
1 year
0.62
Extreme 0.616
19.95
3 years
0.62
Extreme 0.616
52.50
5 years
0.62
Extreme 0.616
93.50
10 years
0.62
Extreme 0.616
465.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 22-02-07
Chief Operating Officer 55 20-12-31
Chief Tech/Sci/R&D Officer 51 17-12-31
Members of the board TitleAgeSince
Chairman 60 20-04-14
Director/Board Member 72 20-04-14
Director/Board Member 64 22-03-31
More insiders
Date Price Change Volume
24-03-28 1 0.00% 1 774
24-03-27 1 -2.44% 11,381
24-03-26 1.025 +0.49% 29,504
24-03-25 1.02 +8.97% 120,175
24-03-22 0.936 +15.27% 142,192

Delayed Quote Swiss Exchange, March 28, 2024 at 04:00 am EDT

More quotes
Evolva Holding SA (Evolva) is a Switzerland-based biotechnology company reseaching, developing and commerzializing nature-based ingrendients. The activity of the Company is divided into two segments: technololgy platforms - combines biology with technology to produce nature-based ingredients; technology servises- provides tailored services to clients across industries. The Company is focused on developing and increase the yield and efficiency of the production of various ingredients.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Evolva Holding SA - Swiss Exchange